Rigel Pharmaceuticals RIGL Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $499.51M.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rigel Pharmaceuticals's market capitalization?
- Rigel Pharmaceuticals (RIGL) reported market capitalization of $499.51M in Q1 2026.
- How has Rigel Pharmaceuticals's market capitalization changed year-over-year?
- Rigel Pharmaceuticals's market capitalization increased by 55.4% year-over-year, from $321.35M to $499.51M.
- What is the long-term trend for Rigel Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's market capitalization has grown at a 5.4% compound annual growth rate (CAGR), from $598.52M to $777.42M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.